Serum Bone Morphogenic Protein-4 Contributes to Discriminating Coronary Artery Disease Severity
Bone morphogenic protein 4 (BMP-4) is a known pro-inflammatory and pro-atherogenic cytokine. Here, we investigated whether the serum BMP-4 level predicts coronary artery disease (CAD) severity in humans.
Main Authors: | Park, Chul Soo, Hong, Oak-Kee, Kim, Mee Kyoung, Chung, Woo Baek, Choi, Yun Seok, Baek, Ki-Hyun, Song, Ki-Ho, Lee, Man Young, Kwon, Hyuk-Sang |
---|---|
Format: | Online |
Language: | English |
Published: |
Wolters Kluwer Health
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616847/ |
Similar Items
-
High glucose and palmitate increases bone morphogenic protein 4 expression in human endothelial cells
by: Hong, Oak-Kee, et al.
Published: (2016) -
Changes in Serum Levels of Bone Morphogenic Protein 4 and Inflammatory Cytokines after Bariatric Surgery in Severely Obese Korean Patients with Type 2 Diabetes
by: Kim, Mee Kyoung, et al.
Published: (2013) -
Acute Myocardial Infarction Is a Risk Factor for New Onset Diabetes in Patients with Coronary Artery Disease
by: Park, Chul Soo, et al.
Published: (2015) -
It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent
by: Kim, Ju-Youn, et al.
Published: (2015) -
Effects of bariatric surgery on metabolic and nutritional parameters in severely obese Korean patients with type 2 diabetes: A prospective 2‐year follow up
by: Kim, Mee Kyoung, et al.
Published: (2013)